Core H: Religious Orders Study Core
核心 H:宗教秩序研究核心
基本信息
- 批准号:10472772
- 负责人:
- 金额:$ 70.65万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAgingAlzheimer disease preventionAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAustraliaAutopsyBiologicalBiological MarkersBlack PopulationsBloodBrainBrain PathologyCell modelChicagoClinicalClinical DataCognitive agingCollaborationsCommunitiesCountryCountyDataData CollectionDementiaDiagnosisDiseaseDisease modelEnrollmentEnsureEtiologyEuropeFar EastFundingGoalsHealthHeterogeneityHumanImpaired cognitionInfrastructureLatinoLatino PopulationLinkMagnetic Resonance ImagingManuscriptsMemoryMethodsMiddle EastMinorityMolecular ProfilingNatureNormalcyNorth AmericaOnline SystemsPaperPathogenesisPeer ReviewPersonsPopulation StudyPrecision HealthProcessRecommendationReligion and SpiritualityReportingResearchResearch PersonnelResearch Project GrantsResource SharingResourcesRisk FactorsSisterSouth AmericaSpecimenStrategic PlanningStructureSystems BiologyTimeWomanWorkbrain magnetic resonance imagingdata managementdata sharingdesignfollow-uphealth disparityhuman dataimprovedin vivoinnovationmenmotor impairmentmultidisciplinaryneuroimagingneuropathologyopen dataoperationoutreachprecision medicinepredictive modelingpublic-private partnershiprecruitreligious order studyresearch clinical testingresearch studytoolvirtual
项目摘要
ABSTRACT – RELIGIOUS ORDERS STUDY CORE
The overall goal of the Religious Orders Study (ROS) Core is to support high quality, cutting edge, research
projects on the etiology, pathogenesis, diagnosis, treatment, and prevention of Alzheimer’s disease and related
dementias (AD/ADRD). The ROS Core will support a wide range of research studies that address several
NAPA milesstones, including, 1) Population Studies; 2) Precision Medicine & Health Disparities; and 3)
Disease Mechanisms, and Biomarkers & Diagnosis. The ROS Core, will 1) recruit, enroll, older Catholic
religious men and women, who agree to annual clinical evaluations, blood draw and brain donation; 2) support
studies: a) of the transition from no cognitive impairment (NCI) to MCI to the earliest stages of dementia; b)
linking risk factors to normality, incident MCI, and incident AD/ADRD; c) of the progression and consequences
of impaired motor function; and 3) facilitate externally funded research that aligns with the recommendations of
the 2017 NIA strategic plan, including studies that: a) recognize the heterogeneity and multifactorial nature of
dementias; b) support extensive molecular profiling to fill the gaps in large-scale human data needed to build
predictive models of disease and wellness; c) employ new research paradigms such as systems biology and
innovative human cell modeling; d) enable rapid and extensive sharing of data, disease models, specimens,
and support open science; e) build multidisciplinary translational teams in virtual and real spaces for these
teams to operate; and f) develop new precompetitive public-private partnerships.
The ROS Core has been in operation since 1994. It supports studies a) of the heteogenety of cognitive aging
and mixed brain pathologies, b) of exensive molecular profiling, c) that employ systems biology and human cell
modeling, d) whose data are rapidly disseminated via the RADC Hub, AMP-AD, and NIAGADS, e) that employ
multi- and inter-disciplinary teams across the country and across the globe, and f) that work in public-private
partnerships in the precompetitive space with AMD-AD and its sister studies. Excluding consortium papers, it
has resulted in more than 650 peer-reviewed manuscripts that have been highly impactful on the field with 4
papers having 1000-1499 citations, 3 with 700-999, and 7 with 500-699. The top 10 papers were cited an
average of 922 times. Further, ROS Core data and biospecimens have been shared with investigators at
nearly all other NIA-funded AD Centers, across the county and north America, south America, Europe, the
middle east, Asia and Australia as further evidence of the value of the resource (see Overall Tables 1-6 and
Resource Sharing Plan). The ROS Core set the standard for harmonization with the Clinical and Latino Cores,
affiliated studies Rush Memory and Aging Project and the Minority Aging Research Study, and with the
Chicago Health and Aging Proect.
摘要 - 宗教秩序研究核心
宗教秩序研究(ROS)核心的总体目标是支持高质量,尖端,研究
关于病因,发病机理,诊断,治疗和预防阿尔茨海默氏病及相关的项目
痴呆症(AD/ADRD)。 ROS核心将支持广泛的研究,以解决几个研究
NAPA里程碑,包括1)人口研究; 2)精确医学与健康差异; 3)
疾病机制以及生物标志物与诊断。 ROS核心,将1)招募,入学,老年天主教徒
宗教男女,同意年度临床评估,抽血和脑部捐赠; 2)支持
研究:a)从没有认知障碍(NCI)到MCI到最早痴呆阶段的过渡; b)
将风险因素与正常性,事件MCI和事件AD/ADRD联系起来; c)进展和后果
运动功能受损; 3)促进与外部资助的研究相吻合的研究
2017年NIA战略计划,包括:a)认识到异质性和多因素的性质
痴呆症; b)支持广泛的分子分析,以填补构建所需的大规模人类数据的空白
疾病和保健的预测模型; c)员工新的研究范式,例如系统生物学和
创新的人类细胞建模; d)能够快速而广泛地共享数据,疾病模型,标本,
并支持开放科学; e)在虚拟和真实空间中建立多学科翻译团队
团队要运营; f)建立新的预竞争性公私伙伴关系。
自1994年以来,ROS核心一直在运行。它支持研究a)认知衰老的异质性
和混合脑病理,b)极端分子分析,c)员工系统生物学和人类细胞
建模,d)其数据通过RADC中心,AMP-AD和Niagads迅速传播,e)使用
全国和全球的多学科团队以及在公私方面工作的f)
与AMD-AD及其姊妹研究的预竞争空间的合作伙伴关系。不包括财团文件
已经产生了650多个同行评审的手稿,这些手稿对该领域产生了极大的影响。
论文具有1000-1499的引用,3篇论文为700-999,其中7条带有500-699。排名前10的论文被引用了
平均922次。此外,ROS核心数据和生物测量已与研究人员共享
几乎所有其他NIA资助的广告中心,遍布县和北美,南美,欧洲,
中东,亚洲和澳大利亚作为资源价值的进一步证据(请参阅总体表1-6和
资源共享计划)。 ROS核心为与临床和拉丁裔核心协调的标准设定了标准
会员研究紧急记忆和衰老项目以及少数族裔老化研究,以及
芝加哥的健康和老龄化培训。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID ALAN BENNETT其他文献
DAVID ALAN BENNETT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID ALAN BENNETT', 18)}}的其他基金
Whole Genome Sequencing and Admixture Analyses of Neuropathologic Traits in Diverse Cohorts in USA and Brazil
美国和巴西不同群体神经病理特征的全基因组测序和混合分析
- 批准号:
10590405 - 财政年份:2023
- 资助金额:
$ 70.65万 - 项目类别:
Use and Impact of Novel and Repurposed Therapeutics for Alzheimer's Disease and Related Dementia in Diverse Populations
新型和改造疗法在不同人群中治疗阿尔茨海默病和相关痴呆症的使用和影响
- 批准号:
10655203 - 财政年份:2023
- 资助金额:
$ 70.65万 - 项目类别:
Genome-wide mapping and integrative analysis of DNA 6mA methylome in human AD brain
人类 AD 大脑 DNA 6mA 甲基化组的全基因组作图和综合分析
- 批准号:
10404653 - 财政年份:2019
- 资助金额:
$ 70.65万 - 项目类别:
Genome-wide mapping and integrative analysis of DNA 6mA methylome in human AD brain
人类 AD 大脑 DNA 6mA 甲基化组的全基因组作图和综合分析
- 批准号:
10172823 - 财政年份:2019
- 资助金额:
$ 70.65万 - 项目类别:
相似国自然基金
温度作用下CA砂浆非线性老化蠕变性能的多尺度研究
- 批准号:12302265
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于波动法的叠层橡胶隔震支座老化损伤原位检测及精确评估方法研究
- 批准号:52308322
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
微纳核壳结构填充体系构建及其对聚乳酸阻燃、抗老化、降解和循环的作用机制
- 批准号:52373051
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
东北黑土中农膜源微塑料冻融老化特征及其毒性效应
- 批准号:42377282
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
高层建筑外墙保温材料环境暴露自然老化后飞火点燃机理及模型研究
- 批准号:52376132
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
The Role of Lipids in Alzheimer's Disease and Related Dementias among Black Americans: Examining Lifecouse Mechanisms
脂质在美国黑人阿尔茨海默病和相关痴呆中的作用:检查生命机制
- 批准号:
10643344 - 财政年份:2023
- 资助金额:
$ 70.65万 - 项目类别:
Enhancing Participation of Historically Minoritized Groups in Alzheimer Disease and Related Dementias Research
加强历史上少数群体对阿尔茨海默病和相关痴呆症研究的参与
- 批准号:
10752461 - 财政年份:2023
- 资助金额:
$ 70.65万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 70.65万 - 项目类别:
Elucidating the dynamical and structural molecular factors at the origin of non-enzymatic protein-protein and protein-DNA cross-links
阐明非酶蛋白质-蛋白质和蛋白质-DNA 交联起源的动力学和结构分子因素
- 批准号:
10709399 - 财政年份:2023
- 资助金额:
$ 70.65万 - 项目类别:
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
免疫调节配体 B7-1 在神经变性中靶向 p75 神经营养蛋白受体
- 批准号:
10660332 - 财政年份:2023
- 资助金额:
$ 70.65万 - 项目类别: